Clinical Trials Browser

Phase 1/2 × Has announcements × Lymphoma, Large-Cell, Anaplastic × Clear all

NCT00939770 2020-06-09

Crizotinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma

Phase 1/2 Completed

122 enrolled 24 charts 2 FDA

Neuroblastoma, Lymphoma, Large-Cell, Anaplastic